Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05773040
What this trial is testing

JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas

Who this might be right for
LymphomasB-cell Lymphomas
M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)Looking for participantsNCT03947450
What this trial is testing

Autologous Volar Fibroblast Injection Into the Stump Site of Amputees

Who this might be right for
AmputationSkin WoundStem Cell
Johns Hopkins University 50
Testing effectiveness (Phase 2)Study completedNCT03130374
What this trial is testing

Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells

Who this might be right for
Tracheal StenosisLaryngeal StenosisMesenchymal Stem Cells
The Republican Research and Practical Center for Epidemiology and Microbiology 12
Very early researchUnknownNCT05239676
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma

Who this might be right for
Lymphoma
Zhejiang University 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT06601868
What this trial is testing

The Impact of Nutritional Optimization to Enhance Postoperative Outcomes Using the R-Support Supplements

Who this might be right for
AbdominoplastyBreast ReductionAutologous Breast Reconstruction+1 more
Universitair Ziekenhuis Brussel 200
Testing effectiveness (Phase 2)UnknownNCT01914913
What this trial is testing

Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Chaitanya Hospital, Pune 15
Early research (Phase 1)Active Not RecruitingNCT04049513
What this trial is testing

ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)

Who this might be right for
Lymphomas Non-Hodgkin's B-CellDiffuse Large B-cell Lymphoma (DLBCL)Primary Mediastinal B-cell Lymphoma (PMBCL)+3 more
Malaghan Institute of Medical Research 30
Large-scale testing (Phase 3)UnknownNCT00499018
What this trial is testing

Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaIPI≥2
Fondazione Italiana Linfomi - ETS 399
Not applicableUnknownNCT04194710
What this trial is testing

Arthroscopic Debridement Versus Autologous Cytokine Rich Serum for the Treatment of Lateral Epicondylitis

Who this might be right for
Epicondylitis, Lateral
Corporacion Parc Tauli 86
Not applicableUnknownNCT04223713
What this trial is testing

4D- Flow- MRI After Aortic Valve Surgery

Who this might be right for
Aortic Valve Disease
Deutsches Herzzentrum Muenchen 30
Early research (Phase 1)UnknownNCT04890574
What this trial is testing

CellMist™ Autologous Cells to Treat Deep Second-Degree Burns

Who this might be right for
BurnsBurns Second DegreeBurns Deep Second Degree
RenovaCare, Inc 14
Not applicableNo Longer AvailableNCT04681118
What this trial is testing

Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Brainstorm-Cell Therapeutics
Early research (Phase 1)UnknownNCT02208713
What this trial is testing

Intramuscular Transplantation of Muscle Derived Stem Cell and Adipose Derived Mesenchymal Stem Cells in Patients With Facioscapulohumeral Dystrophy (FSHD)

Who this might be right for
Dystrophy
Royan Institute 21
Not applicableWithdrawnNCT02668510
What this trial is testing

RCT Comparing ESWT With PRP for Plantar Fasciitis in High Demand Cohort

Who this might be right for
Fasciitis, Plantar
Edna Rath
Testing effectiveness (Phase 2)Study completedNCT00396331
What this trial is testing

AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts

Who this might be right for
Autologous Stem Cell Transplantation
Genzyme, a Sanofi Company 100
Early research (Phase 1)UnknownNCT00935454
What this trial is testing

Hepatocyte Matrix Implant Study

Who this might be right for
Liver DiseaseLiver Cirrhosis
Baermed 10
Not applicableLooking for participantsNCT05706766
What this trial is testing

Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Who this might be right for
Multiple MyelomaStem Cell Transplant Complications
Dana-Farber Cancer Institute 30
Very early researchStudy completedNCT03060551
What this trial is testing

Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients

Who this might be right for
Systemic Sclerosis
Suk-Ho Moon 20
Testing effectiveness (Phase 2)Ended earlyNCT06716853
What this trial is testing

A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma

Who this might be right for
Clear Cell RCC
Genenta Science 10
Early research (Phase 1)Looking for participantsNCT06830031
What this trial is testing

Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell-lymphomaDLBCL, Nos Genetic SubtypesFollicular Lymphoma Grade 3B+3 more
Shanghai Exuma Biotechnology Ltd. 18
Next Page